The Impact of COVID-19 is included in Antidepressant Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Antidepressant Trends and Forecast
The future of the global antidepressant market looks promising with opportunities in the major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder, and panic disorder markets. The global antidepressant market is expected to reach an estimated $21.8 billion by 2030 with a CAGR of 5.3% from 2024 to 2030. The major drivers for this market are rising prevalence of depression, obsessive-compulsive disorder, and other mood disorders across the globe and growing awareness about mental health.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Antidepressant by Segment
The study includes a forecast for the global antidepressant by product, depressive disorder, and region.
Antidepressant Market by Product [Shipment Analysis by Value from 2018 to 2030]:
• Tricyclic Antidepressants
• Selective Serotonin Reuptake Inhibitors
• Serotonin-Norepinephrine Reuptake Inhibitors
• Monoamine Oxidase Inhibitors
• Serotonin Antagonist & Reuptake Inhibitors
• Others
Antidepressant Market by Depressive Disorder [Shipment Analysis by Value from 2018 to 2030]:
• Major Depressive Disorder
• Obsessive-Compulsive Disorder
• Generalized Anxiety Disorder
• Panic Disorder
• Others
Antidepressant Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Antidepressant Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies antidepressant companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the antidepressant companies profiled in this report include-
• Alkermes
• AbbVie
• Eli Lilly
• F. Hoffmann-La Roche
• GlaxoSmithKline
• H. Lundbeck
• Merck
Antidepressant Market Insights
Lucintel forecasts that selective serotonin reuptake inhibitor will remain the largest segment over the forecast period due to rising occurrence of major depressive disorder and anxiety disorders.
Within this market, major depressive disorder will remain the largest segment due to high prevalence of major depressive disorder and increasing awareness towards treatment and management of depression among youth population.
North America will remain the largest region over the forecast period due to increasing cases of depression, surge in the geriatric population, and presence of major players in the region.
Features of the Global Antidepressant Market
Market Size Estimates: Antidepressant market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Antidepressant market size by product, depressive disorder, and region in terms of value ($B).
Regional Analysis: Antidepressant market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different products, depressive disorders, and regions for the antidepressant market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the antidepressant market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the antidepressant market size?
Answer: The global antidepressant market is expected to reach an estimated $21.8 billion by 2030.
Q2. What is the growth forecast for antidepressant market?
Answer: The global antidepressant market is expected to grow with a CAGR of 5.3% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the antidepressant market?
Answer: The major drivers for this market are rising prevalence of depression, obsessive-compulsive disorder, and other mood disorders across the globe and growing awareness about mental health.
Q4. What are the major segments for antidepressant market?
Answer: The future of the antidepressant market looks promising with opportunities in the major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder, and panic disorder markets.
Q5. Who are the key antidepressant market companies?
Answer: Some of the key antidepressant companies are as follows:
• Alkermes
• AbbVie
• Eli Lilly
• F. Hoffmann-La Roche
• GlaxoSmithKline
• H. Lundbeck
• Merck
Q6. Which antidepressant market segment will be the largest in future?
Answer: Lucintel forecasts that selective serotonin reuptake inhibitor will remain the largest segment over the forecast period due to rising occurrence of major depressive disorder and anxiety disorders.
Q7. In antidepressant market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to increasing cases of depression, surge in the geriatric population, and presence of major players in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the antidepressant market by product (tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, monoamine oxidase inhibitors, serotonin antagonist & reuptake inhibitors, and others), depressive disorder (major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder, panic disorder, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Antidepressant Market, Antidepressant Market Size, Antidepressant Market Growth, Antidepressant Market Analysis, Antidepressant Market Report, Antidepressant Market Share, Antidepressant Market Trends, Antidepressant Market Forecast, Antidepressant Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Antidepressant Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Antidepressant Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Antidepressant Market by Product
3.3.1: Tricyclic Antidepressants
3.3.2: Selective Serotonin Reuptake Inhibitors
3.3.3: Serotonin-Norepinephrine Reuptake Inhibitors
3.3.4: Monoamine Oxidase Inhibitors
3.3.5: Serotonin Antagonist & Reuptake Inhibitors
3.3.6: Others
3.4: Global Antidepressant Market by Depressive Disorder
3.4.1: Major Depressive Disorder
3.4.2: Obsessive-Compulsive Disorder
3.4.3: Generalized Anxiety Disorder
3.4.4: Panic Disorder
3.4.5: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Antidepressant Market by Region
4.2: North American Antidepressant Market
4.2.2: North American Antidepressant Market by Depressive Disorder: Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others
4.3: European Antidepressant Market
4.3.1: European Antidepressant Market by Product: Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist & Reuptake Inhibitors, and Others
4.3.2: European Antidepressant Market by Depressive Disorder: Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others
4.4: APAC Antidepressant Market
4.4.1: APAC Antidepressant Market by Product: Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist & Reuptake Inhibitors, and Others
4.4.2: APAC Antidepressant Market by Depressive Disorder: Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others
4.5: ROW Antidepressant Market
4.5.1: ROW Antidepressant Market by Product: Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist & Reuptake Inhibitors, and Others
4.5.2: ROW Antidepressant Market by Depressive Disorder: Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Antidepressant Market by Product
6.1.2: Growth Opportunities for the Global Antidepressant Market by Depressive Disorder
6.1.3: Growth Opportunities for the Global Antidepressant Market by Region
6.2: Emerging Trends in the Global Antidepressant Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Antidepressant Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Antidepressant Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Alkermes
7.2: AbbVie
7.3: Eli Lilly
7.4: F. Hoffmann-La Roche
7.5: GlaxoSmithKline
7.6: H. Lundbeck
7.7: Merck
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Antidepressant Market Report.